Viewing nowYou & Telmisartan 80mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
You & Life Sciences Co., Ltd.

MFDS item code 202000326 · Approved 2020.01.21 · Insurance code 058800410
Treatment of essential hypertension and reduction of cardiovascular disease risk
This drug is used for the treatment of essential hypertension and helps stabilize blood pressure. It is also effective in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in patients at high risk. It is particularly suitable for patients over 55 who cannot use ACE inhibitors and have a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or have diabetes with end-organ damage. This drug can effectively lower the risk of cardiovascular diseases, and it is used not only for blood pressure management but also to improve cardiovascular health.
For essential hypertension, Telmisartan should be administered orally as 40 mg once daily with water, and can be taken regardless of meals. It can be started at 20 mg once daily as needed and may be increased up to 80 mg once daily. The maximum blood pressure-lowering effect occurs 4 to 8 weeks after increasing the dose. To reduce the risk of cardiovascular disease, 80 mg is recommended once daily.
This drug may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately once pregnancy is confirmed. This drug should not be administered to individuals with a hypersensitivity to its components, pregnant women or women of childbearing potential, nursing mothers, patients with severe liver dysfunction, patients with cholestasis or biliary obstruction, hereditary angioedema patients, and patients with diabetes or moderate to severe renal impairment. Caution should be exercised when using this drug in elderly patients, patients with hyperkalemia, patients with mild to moderate liver dysfunction, patients with certain heart valve diseases, patients with ischemic heart disease, patients with gastrointestinal diseases, patients with renal artery hypertension, and patients with severe renal impairment. During treatment, various adverse reactions such as hyperkalemia, renal function impairment, angioedema, hypotension, and liver function abnormalities may occur, so symptoms must be closely monitored, and immediate consultation with a physician is necessary if abnormal symptoms appear. Particularly, a sudden drop in blood pressure may lead to dizziness or fainting, so if these symptoms occur, the patient should be laid down and receive appropriate treatment if necessary. This drug may enhance the blood pressure-lowering effect if used in combination with other antihypertensive agents, so interactions with other medications being taken should be monitored. In addition, the risk of renal function deterioration, hyperkalemia, and hypotension may increase when combined with certain medications, requiring regular blood tests and renal function monitoring. Women who are pregnant or planning to become pregnant should not take this drug, and nursing mothers are advised to discontinue breastfeeding while on this medication. Safety and efficacy in children and adolescents (under 18 years) have not been established, so it is not recommended. In case of overdose, there is a risk of hypotension, arrhythmias, acute renal failure, etc., so immediate treatment at a medical institution is required, and this drug is not removed by dialysis, so caution is needed. This drug should be kept out of the reach of children and the sealed packaging should not be opened until just before use. Dizziness or fainting may occur when driving or operating machinery, so caution is necessary. Patients with gastrointestinal diseases should be careful due to the risk of gastrointestinal bleeding, and patients with decreased renal function are recommended to regularly test serum potassium and creatinine levels.
Urticaria, severe swelling (including angioedema, facial swelling, and angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling of skin, oral/ocular mucosal pain, difficulty breathing or respiratory distress, asthma attacks, respiratory distress accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, loss of consciousness
Upper respiratory tract infections, pharyngitis, sinusitis, urinary tract infections, cystitis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, hyperkalemia, hypoglycemia, hyponatremia, depression, insomnia, anxiety, syncope, drowsiness, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, cough, interstitial lung disease, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, taste disturbances, liver function abnormalities/liver impairment, rash
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a sealed container. Also, it is important to maintain a storage temperature between 1°C and 30°C to safely retain the drug's efficacy.
Oval tablets that are white or almost white
30 tablets/box [(10 tablets/AluAlu) x 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
You & Life Sciences Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.